Editorial board

EDITOR IN CHIEF

Prof. David Janero, Northeastern University, Boston, MA, USA

EDITORIAL ADVISORY BOARD

Prof. Jürgen Bajorath, University of Bonn, Bonn, Germany

Prof. Andreas Bender, University of Cambridge, Cambridge, UK

Dr. David Clark, Charles River, England, UK

Prof. Paula de Oliveira, University of Trás-os-Montes and Alto Douro, Villa Real, Portugal

Dr Li Di, Recursion Pharmaceuticals, Salt Lake City, UT, USA

Prof. Alexander Dömling, University of Groningen, Groningen, Netherlands

Dr. Kurt L Hoffman, Autonomous University of Tlaxcala, Tlaxcala, Mexico

Prof. Bin Hong, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Prof. Allan V Kalueff, Southwest University, Chongqing, China

Dr György M Keserű, The Drug Innovation Centre, Research Centre for Natural Sciences, Magyar, Hungary

Prof. Andre Levchenko, Yale University, New Haven, CT, USA

Prof. Callum MaCrae, Harvard University, Cambridge, MA, USA

Dr Jose L Medina-Franco, National Autonomous University of Mexico, Mexico City, Mexico

Dr Michael Menden, University of Melbourne, Melbourne, Australia

Prof. Richard Plemper, Georgia State University, Atlanta, GA, USA

Prof. Kunal Roy, Jadavpur University, Kolkata, India

Dr. Vijay Singh, Armed Forces Radiobiology Research Institute, Bethesda, MD, USA

Dr Alan Talevi, University of La Plata, Buenos Aires, Argentina

Prof. Anna Tsantili-Kakoulidou, University of Athens, Athens, Greece

Dr. Donna Volpe, U.S. Food and Drug Administration, Silver Spring, MD, USA

Prof. Daniel M Watterson, Northwestern University, Chicago, IL, USA

Dr. Mark Whittaker, Ebryl Ltd, England, UK

Dr. Robert Williams, Cancer Research UK, London, UK

Professor Jean-Yves Winum, University of Montpellier, Montpellier, France

Dr Peng Zhan, Shandong University, Ji'nan, China

Citation search